UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011573
Receipt number R000013536
Scientific Title Discover of disease-susceptibility genes of ocular disease
Date of disclosure of the study information 2013/09/01
Last modified on 2020/03/04 13:35:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Discover of disease-susceptibility genes of ocular disease

Acronym

SNPs of ocular diseases

Scientific Title

Discover of disease-susceptibility genes of ocular disease

Scientific Title:Acronym

SNPs of ocular diseases

Region

Japan


Condition

Condition

Ocular disease patients and healthy volunteers

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

Discover of disease-susceptibility genes of ocular diseases.

Basic objectives2

Others

Basic objectives -Others

SNPs of ocular diseases

Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Revealing disease-susceptibility genes of ocular disease

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1)Ocular disease patients and healthy volunteers
(2)Patients who provided written informed consents to participate the study prior to enrollment

Key exclusion criteria

Other conditions considered inappropriate by attending physician

Target sample size

4000


Research contact person

Name of lead principal investigator

1st name Kubota
Middle name
Last name Toshiaki

Organization

Oita University Faculty of Medicine

Division name

Department of Ophthalmology

Zip code

879-5593

Address

1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, Japan

TEL

097-586-5904

Email

oita_oph-admin@umin.ac.jp


Public contact

Name of contact person

1st name Nakano
Middle name
Last name Satoko

Organization

Oita University Faculty of Medicine

Division name

Department of Ophthalmology

Zip code

879-5593

Address

1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, Japan

TEL

097-586-5904

Homepage URL


Email

oita_oph-admin@umin.ac.jp


Sponsor or person

Institute

Department of Ophthalmology, Oita University Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Medical Foundation TENSHINDO
Oita Prefectural Hospital
Shinbeppu Hospital
BEPPU Medical Center

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Genome, Gene Analysis Research Ethics Committee, Oita University Faculty of Medicine

Address

1-1 Idaigaoka, Hasama-machi, Yufu-City, Oita 879-5593, Japan

Tel

097-586-5110

Email

syomu@oita-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大分大学医学部附属病院(大分県)
天心堂へつぎ病院(大分県)
大分県立病院(大分県)
新別府病院(大分県)
別府医療センター(大分県)


Other administrative information

Date of disclosure of the study information

2013 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2013 Year 01 Month 01 Day

Date of IRB

2012 Year 11 Month 16 Day

Anticipated trial start date

2013 Year 01 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

SNPs of ocular disease


Management information

Registered date

2013 Year 08 Month 24 Day

Last modified on

2020 Year 03 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013536


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name